MT
The startup develops antibody therapeutics using protein engineering to create targeted treatments for various human diseases, including cancer. This approach provides patients with effective alternatives to existing therapies, addressing the need for more personalized and efficient medical solutions.
Toronto, Canada200+ followers
Updated 2 months ago
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops antibody therapeutics using protein engineering to create targeted treatments for various human diseases, including cancer. This approach provides patients with effective alternatives to existing therapies, addressing the need for more personalized and efficient medical solutions.